What is Persyst Development?
Persyst Development operates as a preeminent force in the neurodiagnostics industry, specializing in sophisticated EEG software solutions. The company provides a comprehensive suite of tools, including the Persyst 15 EEG Review and Analysis Software and the Persyst Mobile platform, which are engineered to meet the rigorous demands of both high-volume clinical institutions and community-based medical facilities. By fostering strategic collaborations with leading EEG hardware manufacturers, Persyst ensures seamless interoperability and widespread accessibility of its diagnostic technology. Their commitment to rigorous research and clinical validation has established them as a critical partner for healthcare providers seeking to enhance patient care through advanced neurological monitoring and data-driven insights.
How much funding has Persyst Development raised?
Persyst Development has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Persyst Development
PPP
Public-Private Partnership
What's next for Persyst Development?
With the successful acquisition of this late-stage capital, Persyst Development is poised to accelerate its operational scaling and product innovation cycles. The strategic deployment of these funds will likely focus on deepening the integration of their software with next-generation neurodiagnostic hardware and expanding their footprint in international markets. As the demand for automated, high-accuracy EEG analysis continues to rise, Persyst is strategically aligned to capitalize on the digital transformation of neurology departments. Future growth initiatives will likely prioritize the enhancement of their mobile diagnostic capabilities and the refinement of analytical algorithms to support more complex clinical workflows, ensuring the company remains at the forefront of the neurodiagnostic landscape.
See full Persyst Development company page
